Form 4 for CBLL Ceribell, Inc.
Accepted 2025-12-11 00:00:00 ET · period of report 2025-12-09 · accession 0001193125-25-316126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-11 | 2025-12-09 | CBLL | BURKE WILLIAM W | Dir | M - OptEx | $3.97 | +32.7K | 27.1K | New | +$130.1K |
| DMT | 2025-12-11 | 2025-12-09 | CBLL | BURKE WILLIAM W | Dir | S - Sale+OE | $22.02 | -32.7K | 17.4K | -65% | -$720.7K |
| DMT | 2025-12-11 | 2025-12-09 | CBLL | BURKE WILLIAM W | Dir | M - OptEx | $0.00 | -32.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-09 | M | A | 23,000 | $4.70 | 40,391 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-09 | S | D | 23,000 | $22.02 | 17,391 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.2 to $23.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2025-12-09 | S | D | 9,728 | $22.02 | 17,391 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.23 to $22.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
| 4 | Common | Common Stock | 2025-12-09 | M | A | 9,728 | $2.26 | 27,119 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-12-09 | M | D | 23,000 | $0.00 | 25,151 | D | $4.70 · — to 2032-06-23 | 23,000 Common Stock | (F5) The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of June 23, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-12-09 | M | D | 9,728 | $0.00 | 0 | D | $2.26 · — to 2030-09-10 | 9,728 Common Stock | (F4) The stock option is fully vested and currently exercisable. |